Procarta is granted EU Patent for platform technology

Patent for snare™

The European patent office has granted Procarta a patent on the snare™ platform, which establishes an important monopoly in commercially relevant territories (Patent No. 2205701).

In particular the granted claims encompass use of the oligonucleotide therapeutic (Transcription Factor Decoy, TFD) to treat bacterial infection.

Posted in Press Release and tagged , , , .